Regular ArticleA Prospective Randomized Comparison of 6 and 12 Cycles of Cyclophosphamide, Adriamycin, and Cisplatin in Advanced Epithelial Ovarian Cancer: A Danish Ovarian Study Group Trial (DACOVA)
References (0)
Cited by (147)
Epithelial ovarian cancer
2018, Clinical Gynecologic OncologyNeoadjuvant chemotherapy and chemotherapy cycle number: A national multicentre study
2017, Gynecologic OncologyPrimary peritoneal serous carcinoma treated by cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy. A multi-institutional study of 36 patients
2013, European Journal of Surgical OncologyCitation Excerpt :Modifications in the dose of antineoplastic drug in the HIPEC perfusate may decrease haematological toxicity and this needs further investigation. Median survival projected to be longer than 5 years which is better than that previously reported.8,16,29,30 Survival analyses were performed from the date of surgery and not from initial diagnosis and so may well underestimate survival.
Survival Effect of Maximal Cytoreductive Surgery for Advanced Ovarian Carcinoma During the Platinum Era: A Meta-Analysis
2023, Journal of Clinical Oncology
Copyright © 1993 Academic Press. All rights reserved.